Blog Post Highlights Challenges To, Progress In Vaccine R&D, Access

Global Health Technologies Coalition’s “Breakthroughs”: The R&D agenda and how it addresses access to vaccines
“In this guest post, Dr. Jayasree K. Iyer — chief scientific officer at the Access to Medicine Foundation — writes about the findings from their newest study, which examines the current state of the vaccine pipeline and how large pharmaceutical companies are considering access to these products” (Chmiola, 10/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.